Compugen Stock

Compugen Treasury Stock

Delisted·Jun 15, 2026

The Treasury Stock of Compugen (CGEN) as of Aug 3, 2026 is 555.88 M USD. In the previous year, Treasury Stock was 543.41 M USD — a change of 2.29% (higher).

Treasury Stock

555.88 MUSD

YoY

2.29%

Last updated:

Treasury Stock of Compugen is 2026 555.88 M USD. Treasury Stock of Compugen was 2025 543.41 M USD. It decreases by 2.29% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

Treasury Stock of Compugen is 555.88 M USD in 2026.

Treasury Stock of Compugen changed from 543.41 M USD to 555.88 M USD, representing a 2.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Compugen since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Compugen historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Compugen

All Key Metrics — Compugen